Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bicyclol for chronic hepatitis C.

X Y Yang, Q Zhuo, T X Wu

    The Cochrane Database of Systematic Reviews
    |January 27, 2007
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Study on the risk factors of development for mild cognitive impairment to Alzheimer's disease based on the competitive risk joint model].

    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2026
    Same author

    Live monitoring uncovers divergent epigenetic remodeling during osteogenic and adipogenic differentiation of mesenchymal stem cells.

    Frontiers in cell and developmental biology·2026
    Same author

    [A case of acute ethylene glycol poisoning complicated with acute cerebral infarction].

    Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2026
    Same author

    Observation of Λ[over ¯]p→K^{+}π^{+}π^{-}π^{0} and Λ[over ¯]p→K^{+}π^{+}π^{-}2π^{0}.

    Physical review letters·2026
    Same author

    [Clinical characteristics of pediatric <i>Mycoplasma pneumoniae</i> necrotizing pneumonia with co-infections].

    Zhonghua er ke za zhi = Chinese journal of pediatrics·2026
    Same author

    [Study on the characteristics and differences of intestinal microbiota in children with allergic diseases].

    Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026

    Bicyclol (a synthetic anti-hepatitis drug) showed no significant benefit for Hepatitis C viral clearance in one small trial. However, it did reduce alanine aminotransferase levels, warranting further research.

    Area of Science:

    • Hepatology
    • Pharmacology
    • Clinical Trials

    Background:

    • Bicyclol is a synthetic drug used in China for chronic hepatitis C.
    • Systematic reviews on bicyclol therapy for chronic hepatitis C are lacking.

    Purpose of the Study:

    • To evaluate the benefits and harms of bicyclol in patients with chronic hepatitis C.
    • To synthesize evidence from available randomized clinical trials.

    Main Methods:

    • Comprehensive literature search across multiple databases (Cochrane, MEDLINE, EMBASE, etc.) and contact with manufacturers.
    • Inclusion of randomized clinical trials comparing bicyclol with placebo or other interventions, regardless of publication status or language.
    • Primary outcomes included mortality and liver-related morbidity; secondary outcomes were viral response and liver histology.

    Related Experiment Videos

    Main Results:

    • One small, three-month randomized clinical trial involving 39 patients was identified.
    • Bicyclol did not demonstrate superiority over placebo for Hepatitis C Virus RNA or anti-HCV antibody clearance.
    • A statistically significant decrease in alanine aminotransferase levels was observed with bicyclol treatment.

    Conclusions:

    • The current evidence from one small, short-term trial is insufficient to support or refute the use of bicyclol for chronic hepatitis C.
    • Larger, long-term, randomized, double-blind clinical trials are necessary to determine the efficacy and safety of bicyclol.
    • Bicyclol's use should currently be limited to participation in randomized clinical trials.